PDK1 and hepatocellular carcinoma: 3.5. Pharmacologic Targeting of PDK1 Resensitizes HCC Cells to Radiotherapy-Induced Apoptosis Signals Dose-Dependently, and Significantly Suppress Their Oncogenicity